Effect of a Tailored Multidimensional Intervention on the Care Burden Among Family Caregivers of Stroke Survivors

August 13, 2021 updated by: Mahmoud Ahmed Ahmed Ahmed Elsheikh, Cairo University
Family caregivers are the key persons in the recovery and rehabilitation process of stroke survivors. Despite multiple researches recommended the development of interventions which are based on the family caregivers' needs and recommended the conduction of the interventions based on the integration of skill-building, psychoeducation, and peer support to relieve the care burden they feel, there are no studies conducted to evaluate the effect of such these interventions on the family caregivers of stroke survivors in Egypt. The purpose of this study is to evaluate the effect of a tailored multidimensional intervention on the care burden among family caregivers of stroke survivors. Using a randomized control trial, 110 family caregivers will be recruited from the community; from the outpatient clinics and rehabilitation clinics which are located at Mansoura city (Capital of Dakahlia Governorate) and the surrounding cities and villages. The participants will be randomized through 1:1 open-label randomization to the intervention group and the control group. The intervention group will receive the tailored multidimensional intervention. The intervention will last for 6 months. 3 home visits and 3 telephone interventions and 1 peer support will be conducted during the first 3 months. the home visits and telephone interventions will be conducted biweekly alternately. During the second 3 months, 3 telephone follow-ups will be conducted monthly. Regarding the control group, they will receive a simple educational booklet through one home visit. The primary outcome is the care burden (Zarit Burden Interview) and secondary outcomes are the perceived needs (Family Needs Questionnaire-Revised), coping strategies (Brief Coping Orientation to Problems Experienced) and quality of life (World Health Organization Quality of Life-BREF) among family caregivers. The primary and secondary outcomes will be assessed basically before the intervention and after the 3rd and 6th months since the start of the intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Introduction:

Cardiovascular diseases (CVD) including stroke is the first leading cause of death worldwide. It was estimated 17.9 million people died from CVDs in 2016, representing 31 percentage of all global deaths. Of these deaths, 85 percentage are due to heart attack and stroke. Over 75 percentage of CVD deaths take place in low- and middle-income countries. Besides, stroke is one of the leading causes of severe long-term disability. Stroke is the second cause of Disability-Adjusted Life Years (DALYs) globally after ischemic heart disease. Stroke is the second of DALYs in the developing countries and the third cause to DALYs in the developed countries.

A stroke affecting one of the family members is a stressful event or shock for all family members; especially the primary family caregiver. The concept of stroke is usually attached to chronic functional, cognitive and behavioral changes. These changes require daily assistance for the stroke patients in performing Activities of Daily Livings (ADLs) and Instrumental Activities of Daily Livings (IADLs). A family caregiver is committed to assist the stroke patient to perform these activities.

Caregiving for a stroke survivor creates imbalance and strain between the personal life of the family caregiver and the provision of the caregiving role. Caregiving for stroke survivors conveys physical, psychological, social and financial burdens upon the family caregiver. In addition, the feeling of burden among family caregivers of stroke survivors interferes with the rehabilitation and quality of life of the stroke survivors and increases the risk of mortality.

Since stroke is a sudden condition that forces the family to provide care for their loved person without preparedness, it brings out multiple challenges to which the family caregivers must adapt without compromising their own life. So, the interventions are directed to prepare the family caregivers adequately to be able to perform their caring role and at the same time to reduce the burden of care and to maintain their quality of life.

However, the effectiveness of the interventions to reduce the family caregivers' burden and other negative outcomes is debatable. The statement for healthcare professionals from the American Heart Association and American Stroke Association stated that the reasons for varied results are related to multiple methodological problems. It was recommended that future researches have to focus on a tailored intervention based on the needs of family caregivers. Besides, it was recommended that the multidimensional interventions involving psychoeducation, skill-building, and peer support are the most effective way to relieve the family caregivers' burden and other negative outcomes.

Based on the results of the systematic literature review of the studies that aimed to identify the prevalence and incidence of stroke in Egypt, the mean and median crude prevalence rates were 721.6/100,000 and 655/100,000 respectively. Also, the mean and median crude incidence rates were 187/100,000 and 180.5/100,000 respectively. Regarding the burden levels among the family caregivers, 60 percent of them experiencing severe burden, 24 percentage of them experiencing moderate burden and 16 percentage of them experiencing mild burden.

Stroke survivors immediately discharged from acute hospitals to their homes after the treatment of the acute signs and symptoms. In other words, the families take the responsibility to care for their family member diagnosed with a stroke. This situation exposes the family caregiver at a heightened risk of burden. Especially, there are no specialized nursing homes and there are no home-visiting programs. Family members are rarely provided with sufficient information or training to be equipped to provide home care for stroke survivors. This study aims to develop a tailored multidimensional intervention and to evaluate its effect on the care burden among family caregivers of stroke survivors. There are no similar studies provided to family caregivers of stroke survivors in Egypt.

Aim of the study:

The proposed study aims to evaluate the effect of a tailored multidimensional intervention on the care burden among family caregivers of stroke survivors.

Objectives:

By providing a tailored multidimensional intervention to the family caregivers, the following objectives will be achieved.

Primary objective:

o Relieve the care burden among family caregivers of stroke survivors

Secondary objectives:

  • Meet the perceived needs of family caregivers
  • Enhance the coping strategies among family caregivers of stroke survivors
  • Improve Quality of Life among family caregivers of stroke survivors

Hypotheses:

The family caregivers of stroke survivors who will receive the tailored multidimensional intervention will have a less care burden when they will be compared to the family caregivers allocated in the control group.

Study design:

This study will be open-label, two-arm Randomized Control Trial (RCT)

Study participants:

The study participants are the family caregivers of stroke survivors. The family caregiver is the primary person who regularly provides care for a stroke survivor. The family caregiver may be a son, a daughter, a parent, a spouse, or other relatives.

Sample size:

The sample was calculated based on a similar study which demonstrated a difference in the care burden among the family caregivers (Zarit Burden Interview). The total sample size is 84 family caregivers. It was calculated considering a confidence level of 0.95, a statistical power of 0.90, a minimum effect size of 0.72. 30 percentage of sample size will be recruited additional to the sample size to compensate drop out, so the sample size will be raised to 110 participants. There will be a fair division between the two groups. The sample size was estimated using G power software 3.1.9.4.

Recruitment and randomization:

Basically, the proposed study is a community-based study. Firstly, the researcher will communicate with the physicians at the outpatient clinics and rehabilitation clinics. The researcher will explain to the physicians the aim and the nature of the study and will give them copies of the research proposal. Secondly, the physicians will talk to the family caregivers of the stroke survivors about the proposed study. If the family caregivers accepted to participate in the study, the physicians will give them the contact of the researcher and they will ask the family caregivers for permission to allow the researcher to contact them. After that, the researcher will meet the family caregivers and the stroke survivors to explain to them the purpose and nature of the study. If they accepted to participate in the study, written informed consent will be obtained from the participants. The study participants will be informed all data will be used for research only and they have the right to withdraw from the study at any time.

After the confirmation of the availability of inclusion criteria among the study participants and obtaining informed consent, the allocation of the participants in the Intervention Group (IG) or in the Control Group (CG) will be through 1:1 open-label randomization. Participants will be randomized into one of the two groups after the stratification of the stroke survivors by the dependency level (Modified Rankin scale III or IV or V) and by dementia (Mini-Mental State Examination (MMSE) ≤20 or more than 20). Randomization will be performed by a trained research assistant (randomized allocation center) who is not involved in the intervention or the evaluation. The research assistant will inform the researcher which participants are assigned to the IG and which patients are CG.

  • Initial baseline home visit An initial baseline home visit to both the intervention and control group will be conducted to collect the baseline data. The baseline data will include the demographic characteristics of the family, the family caregivers, the stroke survivors, and the home preparation. It will include also, the general health condition of the family caregiver, the stroke survivors' general health condition, post-stroke complications, and the provided health care services. Besides, baseline data of the primary and secondary outcomes. All baseline data will be collected before the intervention during baseline home visit through self-administered questionnaires and face to face interviews with the participants. After that, tailored plans will be designed based on the needs of the participants.

  • Period of intervention and method of delivery (6 months) The principal investigator will collaborate with other researchers who are academic staff and trained nurses to assist in the conduction of the study. All researchers and nurses will be trained by the principal investigator.

    • First 3 months:

      3 home visits, 3 telephone interventions, and 1 peer support session will be conducted within the first 3 months. Each home visit will last 120 minutes, and each telephone intervention will last 30-40 minutes. The peer support session will last 90 minutes. The home visits and telephone interventions will be conducted biweekly alternatively.

    • Second 3 months:

      3 telephone follow up will be conducted within the second 3 months. One telephone follows up will be conducted every month. Each telephone session will last 30-40 minutes.

Ethical issues and consent:

A primary approval will be granted from the Ethical Research Committee, written consent will be obtained from the family caregivers and the stroke survivors after explaining the purpose, nature, benefits, and risks of the study. The study subjects will be informed all data will be used for research only and they have the right to withdraw from the study at any time.

Data analysis:

To ensure comparability between the intervention group and the control group, all baseline data will be analyzed.

Quantitative variables will be expressed as means and standard deviations. For the qualitative variables, absolute and relative frequencies will be presented. T-test, the Mann-Whitney U test, Pearson's chi-square test or Fisher's exact test and ANOVA and ANCOVA according to normality will be used to compare the groups. One of the three different imputation methods, namely, Baseline Observation Carried Forward (BOCF) or Last Observation Carried Forward (LOCF) or Worst Observation Carried Forward (WOCF) will be used to account for the missing data from the participants who discontinued the study, to evaluate the changes in the primary and secondary outcomes. The significance level will be set at ≤ 0.05. The Statistical Package for Social Sciences (SPSS) version 21.0 will be used for analysis.

Study Type

Interventional

Enrollment (Actual)

110

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
    • Dakahlia
      • Mansoura, Dakahlia, Egypt, 35511
        • Community based study (from the outpatient clinics and the rehabilitation centers at the community at Mansoura city and surrounding cities and villages within Dakahlia)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Participants will be included if they meet the following criteria:

    1. who is 18 years old or more and
    2. who is caring for stroke survivors having stroke within 6 months ago and with modified Rankin scale scores equal 3 to 5.

Exclusion Criteria:

  • Family caregivers will be excluded:

    1. if they have cognitive impairments.
    2. if their stroke survivors have one of the following conditions: (1) the stroke survivors have other limitations of mobility such as (fracture, dislocation, spinal cord injury, spinal vertebrae injury); and (2) the stroke survivor has terminal stage diseases such as end-stage cancer, end-stage liver disease and end-stage kidney disease or any other end-stage diseases.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: SUPPORTIVE_CARE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Intervention Group
Tailored Multidimensional Intervention
Behavioral: Tailored Multidimensional Intervention. the tailored intervention will be implemented through 6 months using a multidimensional approach (skill building, psychoeducation and peer support).
Skill-building can be defined as training the family caregivers the following skills (1) hands-on training in such skills as positioning, transferring and mobility techniques and assistance with activities of daily living; (2) coping strategies and stress management (3) communicating with healthcare professionals. Psycho-education is teaching and provision the family caregivers the knowledge and information regarding stroke (stroke definition, types of stroke, risk factors, prevention of recurrent stroke, medication management, stroke complications and measures for prevention and management of these complications). Besides, family caregivers will be taught and given the knowledge and information regarding managing stroke survivors' emotions and behaviors. Peer support can be defined as engaging the family caregivers of stroke survivors in interactions with their peers for support and exchanging advices and experiences.
NO_INTERVENTION: Control Group
Regarding the control group, the participants will receive a simple educational booklet through one home visit.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the change of the Care burden among family caregivers of stroke survivors (Zarit Burden Interview)
Time Frame: baseline, 3 months, 6 months
Care burden can be defined in this context as the personal strain and role strain that the family caregiver experienced due to caring for one of the family. members having stroke. Consequently, the family caregivers will suffer from physical or psychological or emotional or social or financial complains. The Short version (12 items) of Zarit Burden Interview will be used. Items are rated on a 5-point Likert scale from 0 (never) to 4 (almost always). the validated Arabic version will be used.
baseline, 3 months, 6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measuring the change of the perceived needs of family caregivers of stroke survivors (Family Needs Questionnaire- Revised (FNQ-R)
Time Frame: baseline, 3 months and 6 months
The FNQ-R can be used to develop individualized educational and therapy programs tailored to family members' stated needs. Furthermore, completion of the questionnaire prior to and following intervention helps provide an index of intervention effectiveness. Family caregivers will be asked to indicate the importance to rate the degree to which the need has been met (met, partially met, not met). the tool consists of 37 questions presenting different needs domains. It includes 6 factors (Health Information, Emotional Support, Instrumental Support, Professional Support, Community Support Network and Involvement with Care). the tool will be translated into Arabic context and validity and reliability will be ensured.
baseline, 3 months and 6 months
Measuring the change of the coping strategies among family caregivers of stroke survivors (Brief-COPE (Coping Orientation to Problems Experienced) Inventory)
Time Frame: baseline, 3 months and 6 months
Brief COPE is a 28 items scale measures the ways individuals use to cope with stress in their life. Brief COPE is formed of 14 domains/ scales (each consisted of 2 items) were responses ranged from 1 (I haven't been doing this at all) to 4 (I've been doing this a lot). the validated Arabic version will be used.
baseline, 3 months and 6 months
Measuring the change of the Quality of Life among family caregivers of stroke survivors (WHOQOL-BREF)
Time Frame: baseline, 3 months and 6 months
It consists of 26 questions. It includes 2 general questions, 7 questions regarding physical health, 6 questions regarding psychological, 3 questions regarding social relationships and 8 questions regarding environment. Items are rated on 5-points likert scale (from 1 to 5). The validated Arabic version will be used.
baseline, 3 months and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Cairo University

Collaborators

Mansoura University
Hiroshima University

Investigators

  • Principal Investigator: Mahmoud A Elsheikh, PhD Student, Hiroshima University
  • Study Chair: Michiko Moriyama, Professor, Hiroshima University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

December 27, 2019

Primary Completion (ACTUAL)

November 30, 2020

Study Completion (ACTUAL)

November 30, 2020

Study Registration Dates

First Submitted

December 21, 2019

First Submitted That Met QC Criteria

December 23, 2019

First Posted (ACTUAL)

December 26, 2019

Study Record Updates

Last Update Posted (ACTUAL)

August 19, 2021

Last Update Submitted That Met QC Criteria

August 13, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • P.0195

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

all IPD that underlie results in a publication will be shared to open data repository.

IPD Sharing Time Frame

The dataset was submitted to the Dryad repository in February 2020.

IPD Sharing Access Criteria

Open access

doi:10.5061/dryad.gf1vhhmm5

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Finland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe